• Sílvia Álvares Cardiology Department of Centro Materno Infantil do Porto, Centro Hospitalar do Porto



Download data is not yet available.


Schmied C, Borjesson M. Sudden cardiac death in athletes. J Intern Med 2014; 275: 93–103 doi: 10.1111/joim.12184

Mont L, Pelliccia A, SharmaS et al. Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: position paper from the EHRA and the EACPR, Q2 Q3 branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE. Europace 2017; 19: 139-63. doi:

Harmon KG, Drezner JA, Wilson MG, Sharma S. Incidence of sudden cardiac death in athletes: a state-of-the-art review. Heart 2014;100: 1227 – 34.

Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA. 2006;296: 1593–601

Harmon KG, Asif IM, Maleszewski JJ, Owens DS, Prutkin JM, Salerno JC, et al. Incidence, etiology, and comparative frequency of sudden cardiac death in NCAA athletes: a decade in review. Circulation 2015; 132:10–9

Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980–2006. Circulation 2009; 119: 1085–92

Corrado D, Pelliccia A, Bjornstad HH, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005;26:516–24. doi:10.1093/eurheartj/ehi108

Harmon KG, Zigman M, Drezner JA. The effectiveness of screening history, physical exam, and ECG to detect potentially lethal cardiac disorders in athletes: a systematic review/meta-analysis. J Electrocardiol 2015; 48:329 – 38.

Drezner JA, Ackerman MJ, Anderson J, Ashley E, Asplund CA, Baggish AL, et al. Electrocardiographic interpretation in athletes: the ‘Seattle criteria.’ Br J Sports Med. 2013;47:122-4.

Sheikh N, Papadakis M, Ghani S, Zaidi A, Gati S, Adami PE, Carré F, Schnell F, Wilson M, Avila P, McKenna W, Sharma S. Comparison of electrocardiographic criteria for detection of cardiac abnormalities in elite black and white athletes. Circulation. 2014;129:1637-49.

Riding NR, Sheikh N, Adamuz C, Watt V, Farooq A, Whyte GP, et al. Comparison of three current sets of electrocardiographic interpretation criteria for use in screening athletes Heart 2015;101:384–90. doi:10.1136/heartjnl-2014-306437

Maron BJ, Levine BD, Washington RL, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 2: preparticipation screening for cardiovascular disease in competitive athletes: a Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol 2015;66: 2356–61. doi:10.1016/j.jacc.2015.09.034

Drezner JA, O’Connor FG, Harmon KG et al . AMSSM Position Statement on Cardiovascular Preparticipation Screening in Athletes: Current Evidence, Knowledge Gaps, Recommendations, and Future Directions Clin J Sport Med 2016;26: 347–61.

Hainline B, Drezner J, Baggish A, et al. Interassociation consensus statement on cardiovascular care of college student-athletes. Br J Sports Med 2017;51: 74–85.




How to Cite

Álvares S. CARDIAC PREPARTICIPATION SCREENING FOR THE YOUNG ATHLETE: STILL A MATTER OF CONTROVERSY. REVNEC [Internet]. 2017Apr.3 [cited 2022May29];26(1):7-10. Available from:




Most read articles by the same author(s)

1 2 > >>